Market Cap

UroGen Pharma Ltd. Market Capitalization:

$1.06 Billion

USD as of Jan. 1, 2026

business UroGen Pharma Ltd. Company Profile

UroGen Pharma Ltd. Main Stock Listing

NASDAQ: URGN

Market Capitalization History of UroGen Pharma Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of UroGen Pharma Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $1.06 B 148.18%
Jan. 1, 2025 $428.3 M 0.48%
Jan. 1, 2024 $426.3 M 112.19%
Jan. 1, 2023 $200.9 M 7.38%
Jan. 1, 2022 $187.1 M -65.02%
Jan. 1, 2021 $534.8 M -24.96%
Jan. 1, 2020 $712.7 M -29.00%
Jan. 1, 2019 $1.00 B -15.68%
Jan. 1, 2018 $1.19 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

UroGen Pharma Ltd. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

UroGen Pharma Ltd. has the following listings and related stock indices.


Stock: NASDAQ: URGN

Stock: FSX: UR8

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.